Oral Semaglutide's Kidney Outcome Findings in SOUL Trial Clarified by Mann et al.
Response to Comment on Mann et al. Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257-265.
Study Design
Population
People with type 2 diabetes.
Intervention
Oral semaglutide.
Outcome
Impact on kidney outcomes.
Abstract
Authors of the SOUL trial address a comment regarding the impact of oral semaglutide on kidney outcomes in people with type 2 diabetes.